Skip to main content

JDTic

ADVERTISEMENT
Identification
Molecular formula
C28H41N3O
CAS number
582182-06-9
IUPAC name
4-[3-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)propyl]morpholine
State
State

JDTic is a solid at room temperature.

Melting point (Celsius)
166.50
Melting point (Kelvin)
439.65
Boiling point (Celsius)
450.85
Boiling point (Kelvin)
723.15
General information
Molecular weight
476.66g/mol
Molar mass
476.6550g/mol
Density
1.2180g/cm3
Appearence

JDTic is typically found as a solid.

Comment on solubility

Solubility of 4-[3-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)propyl]morpholine

The solubility of 4-[3-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)propyl]morpholine is influenced by various factors, largely dictated by its molecular structure and the functional groups present. Understanding its solubility properties can act as a vital indicator for its applications in pharmaceutical and chemical industries.

Key Factors Influencing Solubility:

  • Molecular Polarity: The presence of polar functional groups can significantly affect solubility in polar solvents.
  • Hydrogen Bonding: Ability to form hydrogen bonds enhances solubility in water.
  • Size and Complexity: Larger and more complex molecules may demonstrate reduced solubility in conventional solvents.

Generally, compounds with amphiphilic characteristics tend to be more soluble in a variety of solvents, which can be advantageous for drug formulation. For instance, solubility may vary in:

  • Water: Solubility in aqueous solutions is a crucial parameter, especially for bioactive compounds.
  • Organic Solvents: Compounds like this one may exhibit increased solubility in organic solvents due to hydrophobic interactions.

Moreover, in practical terms, achieving adequate solubility is essential for effective *bioavailability*, making it a critical aspect for evaluation during drug development. As a noteworthy remark, even with its complex structure, the precise solubility can vary, thus requiring experimental validation in relevant solvents to ascertain optimal conditions for usage.

Interesting facts

Interesting Facts about 4-[3-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)propyl]morpholine

This complex compound, known for its unique structure, is a fascinating subject of study in the field of medicinal chemistry. Here are some noteworthy points:

  • Structural Uniqueness: The compound features a bicyclic structure known as a diazabicyclo[3.3.1]nonane, which provides significant versatility in molecular interactions. The presence of benzyl groups also contributes to its distinct reactivity.
  • Potential for Drug Development: Compounds like this have shown promise in the development of new pharmaceuticals, particularly in the treatment of neurological disorders. Their ability to cross the blood-brain barrier makes them candidates for central nervous system treatments.
  • Synergistic Effects: The incorporation of both morpholine and bicyclic structures can lead to synergistic effects, enhancing the bioactivity of the compound. This is crucial in drug design where efficacy and specificity are paramount.
  • Research Focus: Many researchers are intrigued by such compounds due to their potential applications in various therapeutic areas, including pain management, mental health, and infectious diseases.
  • Chemical Synthesis: The synthesis of such compounds often involves multi-step reactions that can be challenging yet rewarding, further fueling interest in synthetic methodology within the scientific community.

In summary, 4-[3-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)propyl]morpholine embodies the intricate dance of chemistry, where structure and function intertwine to unravel new possibilities in drug discovery. As investigations continue, who knows what secrets this compound might reveal?